Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 6909415, 15 pages
https://doi.org/10.1155/2017/6909415
Research Article

Ubiquitin-Specific Protease 2 Modulates the Lipopolysaccharide-Elicited Expression of Proinflammatory Cytokines in Macrophage-like HL-60 Cells

1Laboratory of Veterinary Physiology, Department of Veterinary Medicine, School of Veterinary Medicine, Rakuno Gakuen University, 582 Bunkyodai-Midorimachi, Ebetsu, Hokkaido 069-8501, Japan
2Department of Comparative and Experimental Medicine, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Aichi, Japan
3Laboratory of Animal Therapeutics, Department of Veterinary Science, Rakuno Gakuen University, 582 Bunkyodai-Midorimachi, Ebetsu, Hokkaido 069-8501, Japan
4Department of Diabetes, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, 99 Commercial Road, Melbourne, VIC 3004, Australia
5Research Resources Center, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako, Saitama, Japan

Correspondence should be addressed to Hiroshi Kitamura; pj.ca.onukar@rmtk

Received 2 June 2017; Revised 21 July 2017; Accepted 30 July 2017; Published 12 September 2017

Academic Editor: Vera L. Petricevich

Copyright © 2017 Hiroshi Kitamura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. L. Bonta and S. Ben-Efraim, “Involvement of inflammatory mediators in macrophage antitumor activity,” Journal of Leukocyte Biology, vol. 54, no. 6, pp. 613–626, 1993. View at Google Scholar
  2. G. Chinetti-Gbaguidi, S. Colin, and B. Staels, “Macrophage subsets in atherosclerosis,” Nature Reviews Cardiology, vol. 12, no. 1, pp. 10–17, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Boutens and R. Stienstra, “Adipose tissue macrophages: going off track during obesity,” Diabetologia, vol. 59, no. 5, pp. 879–894, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Kawasaki and T. Kawai, “Toll-like receptor signaling pathways,” Frontiers in Immunology, vol. 5, p. 461, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Cabanski, M. Steinmüller, L. M. Marsh, E. Surdziel, W. Seeger, and J. Lohmeyer, “PKR regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages,” American Journal of Respiratory Cell and Molecular Biology, vol. 38, no. 1, pp. 26–31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Takeda and S. Akira, “TLR signalling pathways,” Seminars in Immunology, vol. 16, no. 1, pp. 3–9, 2004. View at Google Scholar
  7. H. Kitamura, M. Ito, T. Yuasa et al., “Genome-wide identification and characterization of transcripts translationally regulated by bacterial lipopolysaccharide in macrophage-like J774.1 cells,” Physiological Genomics, vol. 33, no. 1, pp. 121–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. P. C. Heinrich, J. V. Castell, and T. Andus, “Interleukin-6 and the acute phase response,” Biochemical Journal, vol. 265, no. 3, pp. 621–636, 1990. View at Google Scholar
  9. T. Yamagata and M. Ichinose, “Agents against cytokine synthesis or receptors,” European Journal of Pharmacology, vol. 533, no. 1-2, pp. 289–301, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. K. J. Tracey and A. Cerami, “Tumor necrosis factor: a pleiotropic cytokine and therapeutic target,” Annual Reviews of Medicine, vol. 45, pp. 491–503, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. J. W. Xu, S. Ling, and J. Liu, “Higher-order chromatin regulation of inflammatory gene expression,” Mediators of Inflammation, vol. 2017, Article ID 7848591, 6 pages, 2017. View at Publisher · View at Google Scholar
  12. B. Voleti and A. Agrawal, “Regulation of basal and induced expression of C-reactive protein through an overlapping element for OCT-1 and NF-kappaB on the proximal promoter,” The Journal of Immunology, vol. 175, no. 1, pp. 3386–3390, 2005. View at Google Scholar
  13. B. Petryniak, L. M. Staudt, C. E. Postema, W. T. McCormack, and C. B. Thompson, “Characterization of chicken octamer-binding proteins demonstrates that POU domain-containing homeobox transcription factors have been highly conserved during vertebrate evolution,” Proceedings of National Academy of Sciences of the United States of America, vol. 87, no. 3, pp. 1099–1103, 1990. View at Google Scholar
  14. D. J. Hodson, A. L. Shaffer, W. Xiao et al., “Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 14, pp. E2039–E2046, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Fold, M. Strubin, and N. Hernandez, “The Oct-1 POU domain activates snRNA gene transcription by contacting a region in the SNAPc largest subunit that bears sequence similarities to the Oct-1 coactivator OBF-1,” Genes and Development, vol. 12, no. 22, pp. 3528–3540, 1998. View at Google Scholar
  16. F. Bentrari, A. Chantôme, A. Knights, J. F. Jeannin, and A. Pance, “Oct-2 forms a complex with Oct-1 on the iNOS promoter and represses transcription by interfering with recruitment of RNA PolII by Oct-1,” Nucleic Acids Research, vol. 43, no. 20, pp. 9757–9765, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. K. D. Wilkinson, “Regulation of ubiquitination-dependent processes by deubiquitinating enzymes,” The FASEB Journal, vol. 11, no. 14, pp. 1245–1256, 1997. View at Google Scholar
  18. A. C. Faesen, M. P. Luna-Vargas, and T. K. Sixma, “The role of UBL domains in ubiquitin-specific proteases,” Biochemical Society Transactions, vol. 40, no. 3, pp. 539–545, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. F. E. R. Turcu, K. H. Ventii, and K. D. Wilkinson, “Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes,” Annual Review of Biochemistry, vol. 78, pp. 363–397, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. P. E. Collins, A. Colleran, and R. J. Carmody, “Control of NF-κB subunits by ubiquitination,” Methods in Molecular Biology, vol. 1280, pp. 355–370, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Zinngrebe, A. Montinaro, N. Peltzer, and H. Walczak, “Ubiquitin in the immune system,” EMBO Reports, vol. 15, no. 1, pp. 28–45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. H. D. Scoma, M. Humby, G. Yadav, Q. Zhang, J. Fogerty, and J. C. Besharse, “The de-ubiquitinylating enzyme, USP2, is associated with the circadian clockwork and regulates its sensitivity to light,” PLoS One, vol. 6, no. 9, article e25382, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Kim, W. J. Kim, Z. Liu, M. Loda, and M. R. Freeman, “The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer,” Cell Cycle, vol. 11, no. 6, pp. 1123–1130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Saito, S. Kimura, T. Miyamoto et al., “Macrophage ubiquitin-specific protease 2 modifies insulin sensitivity in obese mice,” Biochemistry and Biophysics Reports, vol. 9, pp. 322–329, 2017. View at Google Scholar
  25. N. Bedard, Y. Yang, M. Gregory et al., “Mice lacking the USP2 deubiquitinating enzyme have severe male subfertility associated with defects in fertilization and sperm motility,” Biology of Reproduction, vol. 85, no. 3, pp. 594–604, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Gousseva and R. T. Baker, “Gene structure, alternate splicing, tissue distribution, cellular localization, and developmental expression pattern of mouse deubiquitinating enzyme isoforms Usp2-45 and Usp2-69,” Gene Expression, vol. 11, no. 3-4, pp. 163–179, 2003. View at Google Scholar
  27. M. M. Molusky, S. Li, D. Ma, L. Yu, and J. D. Lin, “Ubiquitin-specific protease 2 regulates hepatic gluconeogenesis and diurnal glucose metabolism through 11β-hydroxysteroid dehydrogenase 1,” Diabetes, vol. 61, no. 5, pp. 1025–1035, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. K. C. Park, J. H. Kim, E. J. Choi et al., “Antagonistic regulation of myogenesis by two deubiquitinating enzymes, UBP45 and UBP69,” Proceedings of National Academy of Sciences of the United States of America, vol. 99, no. 15, pp. 9733–9738, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Kitamura, S. Kimura, Y. Shimamoto et al., “Ubiquitin-specific protease 2-69 in macrophages potentially modulates metainflammation,” The FASEB Journal, vol. 27, no. 12, pp. 4940–4953, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. X. He, Y. Li, C. Li et al., “USP2a negatively regulates IL-1β- and virus-induced NF-κB activation by deubiquitinating TRAF6,” Journal of Molecular Cell Biology, vol. 5, no. 1, pp. 39–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Sun, Z. Qin, Q. Li et al., “MicroRNA-124 negatively regulates LPS-induced TNF-α production in mouse macrophages by decreasing protein stability,” Acta Pharmacologica Sinica, vol. 37, no. 7, pp. 889–897, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. L. H. Elliott, L. A. Morford, J. P. McGillis, and S. L. Carlson, “Preparation, characterization, and use of human and rodent lymphocytes, monocytes, and neutrophils,” Methods in Neurosciences, vol. 24, pp. 115–150, 1995. View at Google Scholar
  33. S. R. Himes, H. Tagoh, N. Goonetilleke et al., “A highly conserved c-fms gene intronic element controls macrophage-specific and regulated expression,” Journal of Leukocyte Biology, vol. 70, no. 5, pp. 812–820, 2001. View at Google Scholar
  34. H. Kitamura, Y. Naoe, S. Kimura et al., “Beneficial effects of Brazilian propolis on type 2 diabetes in ob/ob mice: possible involvement of immune cells in mesenteric adipose tissue,” Adipocytes, vol. 2, no. 4, pp. 227–236, 2013. View at Publisher · View at Google Scholar
  35. M. N. Cruickshank, E. Fenwick, M. Karimi, L. J. Abraham, and D. Ulgiati, “Cell- and stage-specific chromatin structure across the complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-β binding in B cells,” Molecular Immunology, vol. 46, no. 13, pp. 2613–2622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Hijikata, H. Kitamura, Y. Kimura et al., “Construction of an open-access database that integrates cross-reference information from the transcriptome and proteome of immune cells,” Bioinformatics, vol. 23, no. 21, pp. 2934–2941, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. A. L. Mahul-Mellier, E. Pazarentzos, C. Datler et al., “De-ubiquitinating protease USP2a targets RIP1 and TRAF2 to mediate cell death by TNF,” Cell Death and Differentiation, vol. 19, no. 5, pp. 891–899, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Metzig, D. Nickles, C. Falschlehner et al., “An RNAi screen identifies USP2 as a factor required for TNF-α-induced NF-κB signaling,” International Journal of Cancer, vol. 129, no. 3, pp. 607–618, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Li, X. He, S. Wang, H. B. Shu, and Y. Liu, “USP2a positively regulates TCR-induced NF-κB activation by bridging MALT1-TRAF6,” Protein and Cell, vol. 4, no. 1, pp. 62–70, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Ohtake, Y. Saeki, S. Ishido, J. Kanno, and K. Tanaka, “The K48-K63 branched ubiquitin chain regulates NF-κB signalling,” Molecular Cell, vol. 64, no. 2, pp. 251–266, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. S. C. Lu, H. W. Wu, Y. J. Lin, and S. F. Chang, “The essential role of Oct-2 in LPS-induced expression of iNOS in RAW 264.7 macrophages and its regulation by trichostatin A,” American Journal of Physiology Cell Physiology, vol. 296, no. 5, pp. C1133–C1139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Ramadori, J. Van Damme, H. Rieder, and K. H. Meyer zum Büschenfelde, “Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1β and tumor necrosis factor-α,” European Journal of Immunology, vol. 18, no. 8, pp. 1259–1264, 1988. View at Publisher · View at Google Scholar · View at Scopus
  43. R. A. Turnbull and C. Rivier, “Regulation of the HPA axis by cytokines,” Brain, Behavior, and Immunity, vol. 9, no. 4, pp. 253–275, 1995. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Gewies and S. Grimm, “UBP41 is a proapoptotic ubiquitin-specific protease,” Cancer Research, vol. 63, no. 3, pp. 682–688, 2003. View at Google Scholar
  45. C. Priolo, D. Tang, M. Brahamandan et al., “The isopeptidase USP2a protects human prostate cancer from apoptosis,” Cancer Research, vol. 66, no. 17, pp. 8625–8632, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Ceredig and A. G. Rolink, “The key role of IL-7 in lymphopoiesis,” Seminars in Immunology, vol. 24, no. 3, pp. 159–164, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. T. T. Lu and J. T. Browning, “Role of the lymphotoxin/LIGHT system in the development and maintenance of reticular networks and vasculature in lymphoid tissues,” Frontiers in Immunology, vol. 5, p. 47, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Kang and D. D. Sandy, “Cytokine functions in the formative stage of lymphocyte’s life,” Current Opinion in Immunology, vol. 16, no. 2, pp. 180–190, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Tiedt, B. A. Bartholdy, G. Matthias, J. W. Newell, and P. Matthias, “The RING finger protein Siah-1 regulates the level of the transcriptional coactivator OBF-1,” The EMBO Journal, vol. 20, no. 15, pp. 4143–4152, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Thevenon, E. Engel, A. Avet-Rochex et al., “The drosophila ubiquitin-specific protease dUSP36/Scny targets IMD to prevent constitutive immune signaling,” Cell Host and Microbe, vol. 6, no. 4, pp. 309–320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Pance, “Oct-1, to go or not to go? That is PolII question,” Biochimica et Biophysica Acta Gene Regulatory Mechanisms, vol. 1859, no. 6, pp. 820–824, 2016. View at Publisher · View at Google Scholar · View at Scopus